Lipidor AB Logo

Lipidor AB

Develops topical skin treatments by reformulating drugs with a lipid-based delivery platform.

LIPI | ST

Overview

Corporate Details

ISIN(s):
SE0012558617 (+1 more)
LEI:
549300OC9DDXCE1GMX60
Country:
Sweden
Address:
C/O Ekonomistubben AB, 102 16 Stockholm
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Lipidor AB is a pharmaceutical research and development company specializing in topical treatments for skin diseases. The company's core asset is its proprietary lipid-based drug delivery platform, AKVANO®. Lipidor's business model focuses on reformulating existing active pharmaceutical ingredients into new, innovative, and patient-friendly treatments. This approach offers an accelerated path to regulatory approval and commercialization for its global pharmaceutical partners. The AKVANO® platform is designed to enhance patient compliance by creating formulations that are easy to apply, quick-drying, and less likely to cause skin irritation. The company maintains a pipeline of development projects in various pre-clinical and clinical phases for a wide range of dermatological conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Lipidor AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Lipidor AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Lipidor AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
PRAP Japan,Inc. Logo
A PR & communications firm building brand reputation for corporate clients in diverse industries.
Japan 2449
Psomagen, Inc. Logo
A CRO providing multiomics services & data analysis for academic, biotech, and pharma researchers.
United States of America 950200
Public Policy Holding Company, Inc. Logo
Advisory group providing public policy, government relations, and strategic communications services.
United States of America PPHC.L
Purple Biotech Ltd. Logo
Developing cancer therapies to overcome tumor immune evasion and drug resistance.
Israel PPBT
QUIA PHARMA AB Logo
Develops biobetters by enhancing approved drugs with a patented drug delivery platform.
Sweden QUIA
Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea 115180
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan 4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan 6098
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan 4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan 6045

Talk to a Data Expert

Have a question? We'll get back to you promptly.